SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Nov 25 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maximum_Gain who wrote (3736)1/14/2000 11:12:00 PM
From: Maximum_Gain  Read Replies (1) of 4140
 
Here's a little diddy about SNRS

The NEWS:

Shares of Sunrise Technologies (SNRS: news, msgs) soared 5 15/16,
or 59 percent, to 16 over Island. A U.S. Food and Drug Administration
panel unanimously recommended the approval of the company's
farsightedness laser treatment. The company said it will work with the
agency to get final clearance "in the coming weeks."

OVERNIGHT:

Longs all night are basking in the long awaited approval, posting to the message boards gloating of victory, spewing about how much money
they are going to make, and that they deserve it for a long time of hard work....... Our leader Tony nonstop through out the night post due
diligence about valuation, and the whole marketmaker pro thing.......

To: +WILLIAM BLACK (3622 )
From: +CUBBY Thursday, Jan 13 2000 4:55PM ET
Reply # of 3738

WE WON! CONGRATULATIONS TO ALL THE OLDTIMERS.

CUBBY
To: +Paul A (3638 )
From: +steve susko Thursday, Jan 13 2000 7:28PM ET
Reply # of 3738

SNRS @ 20 !!!

another Areil!
To: +Joe (3637 )
From: +Double E Thursday, Jan 13 2000 10:39PM ET
Reply # of 3738

Joe and all the "Old Timers"

I will never forget how I felt as the July events unfolded and we all shared in that.

But today, that seems like a long, long time ago!

I'll never forget this one either . . . in the words of Nanny when we first hit $2 or $3 or something . . .

"YEEEEEEEEEEEEEEE HAAAAAAAAAAAAAAAAAAA ! ! !"

Hold on tight now!

Best of luck to us all and thanks to everyone for holding the ship together.

Double E



THE VOICE OF REASON SPEAKS:

To: +Auric Goldfinger (3651 )
From: +Anthony@Pacific Thursday, Jan 13 2000 11:49PM ET
Reply # of 3738

SNRS<-------- TRADING AT ALMOST 9000 TIMES SALES!!!!!!!

VISX is roughly trading at 12 times sales.........

SNRS has been trying to sell their lasers for one year in Europe and has accomplished the miraculous job of getting 21,000 in sales in 1 year
...........

are we to believ that Europeans dont have eye problems But we do...............

LONGS get a reprieve from sheer destruction But only cause the Company Used all the smoke and mirrors In the magic Shop..to stay
alive......

I hear LEHMAN pillaged them ............


7:30 MAX wakes up, showers shaves, goes to work ( cash in his margin account, flat SNRS)

9:36
To: +Anthony@Pacific (3705 )
From: +Anthony@Pacific Friday, Jan 14 2000 9:36AM ET
Reply # of 3738

SNRS<---- sell short @ 15-17 (20%) 10% 18, 19,20,21,22,23,24...100

Longs still gloating waiting for the promised land to explode on to thier landscape... (What they don't know is it will never happen)

10:00 am bob enters his first short order..... filled at 14.00

FOR THE REST OF THE DAY THE STOCK TANKS AS LONGS LOOK AT ONE ANOTHER IN DISBELIEF.

SELLLLLLING SELLLING SELLING

To: +CUBBY (3626 )
From: +Anthony@Pacific Friday, Jan 14 2000 12:13AM ET
Reply # of 3738

You won a super expensive pair of reading glasses..Congrats


MORE NEWS:

Sunrise Technologies (NASDAQ:SNRS - news) rose $3.69, or 37%, to $13.75 after a Food and Drug Administration panel recommended
approval of its laser for
the treatment of farsightedness late yesterday. Specifically, it recommended that Sunrise's laser be approved for the “temporary reduction” of
low-to-moderate
farsightedness, a label that the FDA will give a final rule on in the coming weeks.

“Labels are important as guides, but I don't think it will dull the appetite for this procedure,” says Kenneth Goldman, M.D., a Lehman
Brothers analyst with a “buy”
rating and $19 price target.

Its laser employs bursts of heat to reshape the cornea and improve vision, a less invasive procedure compared to excimer lasers that use a
Lasik technique and
require a blade incision on the eye before correction. Sunrise's market is estimated to be over 30 million Americans.

Analyst put out a hold rec target of $3.50 in 12 months

THE REALITY SETS IN:

2:53 MAX Shorts more at 12.00 volume 16 million

SNRS closes at 11 1/2 o 21 million shares

Afterhours it loses 11 and trades to 10 1/2

The final tally on the site is over 800,000 shares short.........

Thank you FDA

Will cover in single digits by wed..........

Sunrise sunset.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext